New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

The company is developing generative AI methods to design proteins from scratch, with applications in drug discovery and ...

Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

XoZymes replaces traditional chemical production methods with an approach that integrates widely available feedstocks like sugar and biomass with advanced enzymes engineered to thrive outside living ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

AI-driven precision wellness empowers proactive health choices through genomics, digital twins, and predictive insights—reshaping medicine from reactive to preventative ...

FDA proposes draft guidelines on AI use in drug development, addressing challenges and opportunities for improving safety and ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

“This is an exciting study. The fact that most of the risk factors identified are modifiable highlights an enormous opportunity for prevention. By addressing social inequalities, promoting healthy ...

It's been seven years since I started selling online courses for the construction inspection industry. My online education ...

It highlights the latest advancements, explains the role of AI in enhancing IoT, details how AI can be integrated, and ...